Tue Nov 20 20:05:26 +0000 2018,Anti-venom maker BTG’s £3.3bn antidote to Faangs https://t.co/AZBMC62GC7,0
Tue Nov 20 16:53:21 +0000 2018,Less than a week after announcing a restructuring plan  @bostonsci dropped $4.2B to acquire London-based @BTG. $BSX… https://t.co/JpjmTxOgzc,1
Tue Nov 20 16:52:32 +0000 2018,Less than a week after announcing a restructuring plan  @bostonsci dropped $4.2B to acquire London-based @BTG. $BSX… https://t.co/JpjmTxOgzc,1
Tue Nov 20 16:22:02 +0000 2018,BTG’s three main businesses—including cancer and vascular interventions  and a portfolio of specialty antidotes for… https://t.co/ipvJ9oocOL,2
Tue Nov 20 16:20:35 +0000 2018,BTG’s three main businesses—including cancer and vascular interventions  and a portfolio of specialty antidotes for… https://t.co/ipvJ9oocOL,2
Tue Nov 20 16:18:48 +0000 2018,BTG’s three main businesses—including cancer and vascular interventions  and a portfolio of specialty antidotes for… https://t.co/ipvJ9oocOL,2
Tue Nov 20 12:45:41 +0000 2018,Stocks to watch: BTG  Wetherspoon  Melrose Industries https://t.co/7wmOsqwmOc,0
Tue Nov 20 12:01:04 +0000 2018,Boston Scientific makes $4․2bn play for UK’s BTG https://t.co/1rGocEXl9k,0
Tue Nov 20 11:40:20 +0000 2018,Boston Scientific makes $4․2bn play for UK’s BTG https://t.co/6DZ4xPdx4x,0
Tue Nov 20 11:28:24 +0000 2018,Boston Scientific agrees to buy Britain's BTG for $4.2 billion  https://t.co/O5E0IHVGLK,0
